MHRA announced Angela Thomas as the new vice-chair of its Commission on Human Medicines (CHM) in mid-January. The CHM advises on matters relating to safety, quality, and efficacy of drugs, as well collecting adverse drug reaction reports. Thomas has been on the CHM since 2005, where she chairs the Clinical Trials, Biologicals & Vaccines Expert Advisory Group.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
